Company / Current Assets
Fulgent Genetics, Inc. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$550.5M
FY2025
5-year range
$353.6M / $627.9M
FY2021-FY2025
Trend
+55.7%
vs FY2024
Sector context
#106 of 160
Health Care
What the data says
At $550M, Fulgent Genetics, Inc.'s current assets ranks #106 of 160 in the Health Care sector. Current Assets returned to growth in FY2025 after 2 years of decline, reaching $550M.
Based on SEC 10-K filings.
$550M in FY2025 with a 5-year CAGR of +1.0%.
Improved from $508M to $550M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -4.3%
- 5-Year CAGR
- +1.0%
- 10-Year CAGR
- -
Sector benchmark
#106 of 160 in Health CareTop 66% of 160This company $550.5M Sector average $5.2B
▼
-89.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +1.0%, indicating consistent growth.
- In FY2025, current assets increased 55.7% year-over-year.
- Ranks #106 out of 160 companies in the Health Care sector.
- Peak current assets was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 5.28 (safe zone, above 2.9 threshold)
- Negative profit margin: -15.1%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $550.5M | +55.7% |
| FY2024 | $353.6M | -30.4% |
| FY2023 | $507.8M | -19.1% |
| FY2022 | $627.9M | +2.6% |
| FY2021 | $612.0M | +16.9% |
| FY2020 | $523.6M | +1312.2% |
| FY2019 | $37.1M | -6.2% |
| FY2018 | $39.5M | +20.1% |
| FY2017 | $32.9M | +26.0% |
| FY2016 | $26.1M | +792.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026